M06.239 Rheumatoid bursitis, unspecified wrist

Name of the Condition

• Rheumatoid bursitis, unspecified wrist

Summary

Rheumatoid bursitis of the unspecified wrist is inflammation of the bursae (fluid-filled sacs that cushion joints) in the wrist region, driven by rheumatoid arthritis (RA). This condition results from the immune system’s chronic inflammatory processes affecting the wrist’s protective structures, leading to pain, swelling, and restricted mobility. Diagnosis requires correlation of clinical findings with RA history or serologic evidence.

Causes

Rheumatoid bursitis in the unspecified wrist arises from the systemic inflammation of rheumatoid arthritis. The immune system’s attack on joint tissues extends to the wrist’s bursae, causing fluid accumulation and irritation. While RA is the primary driver, mechanical stress or trauma to the wrist may exacerbate inflammation in susceptible individuals.

Risk Factors

• Preexisting rheumatoid arthritis, increasing bursal inflammation risk.
• Advanced age, as RA severity often progresses over time.
• Prolonged wrist overuse or pressure, which may irritate bursae.
• Systemic inflammation, as seen in active RA flares.

Symptoms

• Localized swelling and tenderness over the wrist bursae.
• Pain with wrist movement or pressure on the inflamed area.
• Reduced range of motion in the wrist joint.
• Warmth or redness (if inflammation is acute).

Diagnosis

Diagnosis of rheumatoid bursitis in the unspecified wrist involves clinical evaluation of wrist symptoms, including swelling, tenderness, and restricted motion, combined with a history of rheumatoid arthritis. Imaging (e.g., ultrasound or MRI) may confirm bursal inflammation, while serologic tests (e.g., rheumatoid factor, anti-CCP antibodies) support the underlying RA diagnosis. Exclusion of other causes, such as infection or crystal-induced bursitis, is essential.

Treatment Options

Treatment focuses on reducing inflammation and managing RA. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections may alleviate pain and swelling. Disease-modifying antirheumatic drugs (DMARDs) or biologics target systemic RA activity. Physical therapy helps maintain wrist function, and activity modification reduces mechanical stress.

Prognosis and Follow-Up

Prognosis depends on RA control; effective management of underlying disease often improves bursitis symptoms. Regular follow-up with a rheumatologist monitors RA activity and adjusts treatment. Persistent inflammation may require repeated interventions, and joint damage risk increases with uncontrolled disease.

Complications

Untreated or poorly controlled inflammation may lead to chronic pain, reduced wrist mobility, or bursal thickening. Severe cases can contribute to joint degeneration or secondary infections. Systemic RA complications (e.g., cardiovascular disease) may also impact overall health.

Lifestyle & Prevention

• Manage RA with prescribed medications to reduce systemic inflammation.
• Avoid repetitive wrist motions or prolonged pressure on the affected area.
• Use ergonomic tools or supports during activities to minimize stress.
• Maintain a healthy weight to reduce joint load.

When to Seek Professional Help

Seek care if wrist pain, swelling, or stiffness worsens, limits daily activities, or persists despite home care. Immediate attention is needed for sudden severe pain, redness, or fever, which may indicate infection.

Tips for Medical Coders

Document the wrist involvement as "unspecified" when the left or right side is not clinically specified. Ensure correlation with rheumatoid arthritis diagnosis and note any imaging or serologic findings supporting bursitis. Avoid assuming laterality without explicit clinical documentation.